Q2B25 Silicon Valley | Scott Buchholz, Managing Director, Deloitte @QCWare

Q2B25 Silicon Valley | Scott Buchholz, Managing Director, Deloitte @QCWare

Uploaded January 2026 | Updated September 2026, 2 weeks ago

Deloitte: Quantum Computing Use Cases for Life Sciences and Healthcare |
Scott Buchholz, Managing Director, Deloitte

q2b.qcware.com

Q2B25 Silicon Valley | Scott Buchholz, Managing Director, Deloitte

Q2B26 Tokyo | Xinchi Huang(黄欣馳), Quemix, Inc. and Tomofumi Zushi(図師知文), Sumitomo Rubber Ind., Ltd.

Q2B25 Silicon Valley | John Preskill, Professor, California Institute of Technology

Q2B26 Tokyo | Taichi Kosugi, Quemix Inc. and Hiroki Takahashi(高橋広己), Mitsui Kinzoku Company, Ltd.

Q2B25 Silicon Valley | Yonatan Cohen, Co founder & CTO, Quantum Machines

Q2B26 Tokyo | Yu-ichiro Matsushita, CEO & President, Quemix, Inc.

Q2B26Tokyo | Mitsuhisa Sato, Division Director of Quantum-HPC Hybrid Platform Division, RIKEN

Q2B25 Paris | Fostering Practical Explorations through the Paris Region Quantum Pack

Q2B26 Tokyo | Shuntaro Takeda, Associate Professor, The University of Tokyo

Q2B25 Paris | Alfredo Massa, Researcher, QauntumNet SRL

Q2B25 Paris | Anders Broo, Executive Director, Head of Data Science & Modelling, AstraZeneca

Q2B25 Paris | Dorit Dor, Co founder, QBeat Ventures

Q2B25 Silicon Valley | Scott Buchholz, Managing Director, Deloitte